1/13/25 07:00 | 1/10/25 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 21 | 2.08 | 0 | 10 | 2 | 660 | D | | | | | | | | | | | | | | |
7/1/24 16:30 | 7/1/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 100 | 5.33 | 0 | 19 | 3 | 650 | D | | | | | | | | | | | | | | |
6/20/24 08:30 | 6/18/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 30 | 2.08 | 0 | 14 | 2 | 631 | D | | | | | | | | | | | | | | |
1/2/24 17:43 | 1/2/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 19 | 2.08 | 0 | 9 | 1 | 616 | D | | | | | | | | | | | | | | |
11/6/23 18:00 | 11/3/23 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 42 | 2.08 | 0 | 20 | 3 | 607 | D | | | | | | | | | | | | | | |
8/8/23 16:30 | 8/8/23 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 25 | 2.08 | 0 | 12 | 2 | 587 | D | | | | | | | | | | | | | | |
12/8/22 18:11 | 12/8/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 21 | 2.08 | 0 | 10 | 2 | 574 | D | | | | | | | | | | | | | | |
10/17/22 20:09 | 10/17/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 124 | 2.08 | 0 | 60 | 12 | 562 | D | | | | | | | | | | | | | | |
5/3/22 19:27 | 5/3/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 42 | 2.08 | 0 | 20 | 4 | 502 | D | | | | | | | | | | | | | | |